Alex Nemiroff
Vermogen: 9 M $ op 31-05-2026
Vermogen: 9 M $ op 31-05-2026
Alex Nemiroff is the founder of RogCon, Inc., established in 2015, holding the title of Chief Executive Officer.
Mr. Nemiroff is the founder of RogCon U.R., Inc., established in 2015, holding the title of Chief Executive Officer.
Mr. Nemiroff currently works at Praxis Precision Medicines, Inc. as Secretary & General Counsel since 2020.
Mr. Nemiroff completed undergraduate education at Stephen M.
Ross School of Business and graduate education at Northwestern University School of Law.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-05-2026 | 26.011 ( 0,09% ) | 9 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Algemeen Adviseur | 01-01-2020 |
RogCon, Inc.
RogCon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company focused on drug research, discovery and development | Algemeen Directeur | 01-11-2015 |
RogCon U.R., Inc. | Algemeen Directeur | 01-11-2015 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwestern University School of Law
Northwestern University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
RogCon, Inc.
RogCon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company focused on drug research, discovery and development | Health Technology |
RogCon U.R., Inc. |
Kies jouw editie
Alle financiële informatie op nationaal niveau